Immune Reconstitution During the First Year of Antiretroviral Therapy of HIV-1-Infected Adults in Rural Burkina Faso
The Open AIDS Journal · 24.02.2012 · 6 (1) · 16-25
DOI: 10.2174/1874613601206010016 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open AIDS Journal, erschienen am 24.02.2012. Verfasst von Fabrice Tiba und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Virology, University of Heidelberg, INF324, D-69120 Heidelberg, Germany. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
There are no data on the outcome of highly active antiretroviral therapy (HAART) in HIV-infected adults in rural Burkina Faso. We therefore assessed CD4 + T-cell counts and HIV-1 plasma viral load (VL), the proportion of naive T-cells (co-expressing CCR7 and CD45RA) and T-cell activation (expression of CD95 or CD38) in 61 previously untreated adult patients from Nouna, Burkina Faso, at baseline and 2 weeks, 1, 3, 6, 9 and 12 months after starting therapy. Median CD4 + T-cell counts increased from 174 (10 th -90 th percentile: 33-314) cells/µl at baseline to 300 (114- 505) cells/µl after 3 months and 360 (169-562) cells/µl after 12 months of HAART. Median VL decreased from 5.8 (4.6- 6.6) log10 copies/ml at baseline to 1.6 (1.6-2.3) log10 copies/ml after 12 months. Early CD4 + T-cell recovery was accompanied by a reduction of the expression levels of CD95 and CD38 on T-cells. Out of 42 patients with complete virological follow-up under HAART, 19 (45%) achieved concordant good immunological (gain of ≥100 CD4 + T-cells/µl above baseline) and virological (undetectable VL) responses after 12 months of treatment (intention-to-treat analysis). Neither a decreased expression of the T-cell activation markers CD38 and CD95, nor an increase in the percentage of naive T-cells reliably predicted good virological treatment responses in patients with good CD4 + T-cell reconstitution. Repeated measurement of CD4 + T-cell counts during HAART remains the most important parameter for immunologic monitoring. Substitution of repeated VL testing by determination of T-cell activation levels (e.g., CD38 expression on CD8 + T-cells) should be applied with caution.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Virology, University of Heidelberg, INF324, D-69120 Heidelberg, Germany.
Zitieren
APA
Tiba, F., Nauwelaers, F., Traoré, S., Coulibaly, B., Ouedraogo, T., Compaoré, A., Kräusslich, H. G., & Böhler, T. (2012). Immune Reconstitution During the First Year of Antiretroviral Therapy of HIV-1-Infected Adults in Rural Burkina Faso. The Open AIDS Journal, 6(1), 16-25. https://doi.org/10.2174/1874613601206010016
Vancouver
Tiba F, Nauwelaers F, Traoré S, Coulibaly B, Ouedraogo T, Compaoré A, et al. Immune Reconstitution During the First Year of Antiretroviral Therapy of HIV-1-Infected Adults in Rural Burkina Faso. The Open AIDS Journal. 2012;6(1):16-25. doi:10.2174/1874613601206010016
BibTeX
@article{Tiba2012,
author = {Tiba, Fabrice and Nauwelaers, Frans and Traoré, Siaka and Coulibaly, Boubacar and Ouedraogo, Thierry and Compaoré, Adama and Kräusslich, Hans-Georg and Böhler, Thomas},
title = {Immune Reconstitution During the First Year of Antiretroviral Therapy of HIV-1-Infected Adults in Rural Burkina Faso},
journal = {The Open AIDS Journal},
year = {2012},
volume = {6},
number = {1},
pages = {16--25},
doi = {10.2174/1874613601206010016}
}
EUVIMED